Skip Navigation LinksHome > October 2013 - Volume 36 - Issue 5 > Primary Cutaneous Anaplastic Large-cell Lymphoma
American Journal of Clinical Oncology:
doi: 10.1097/COC.0b013e3182185aa2
Review Articles

Primary Cutaneous Anaplastic Large-cell Lymphoma

Perry, Edward MD; Karajgikar, Jay BA; Tabbara, Imad A. MD

Collapse Box


Since the recognition of the anaplastic large-cell lymphomas in the 1980s, much has been learned about the diagnosis, clinical presentation, and treatment of these malignant conditions. The systemic and primary cutaneous types of anaplastic large cell lymphomas have been differentiated on clinical and immunophenotypical findings, but further research is required to elucidate their exact etiologies and pathogeneses. Primary cutaneous anaplastic large-cell lymphoma has a 95% disease-specific 5-year survival, owing partly to the relatively benign course of the disease and partly to the variety of effective treatments that are available. As with many other oncological diseases, new drugs are continually being tested and developed, with immunotherapy and biological response modifiers showing promise.

© 2013 by Lippincott Williams & Wilkins, Inc


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.